Academy of Military Medical Sciences

The Academy of Military Medical Sciences (AMMS) of the PLA Academy of Military Science (Chinese: 中国人民解放军军事科学院军事医学研究院) is a Chinese military medical research institute.[1][2] It was established in Shanghai in 1951.[3] It has been based in Beijing since 1958.

Academy of Military Medical Sciences
Simplified Chinese中国人民解放军军事科学院军事医学研究院
Traditional Chinese中國人民解放軍軍事科學院軍事醫學研究院
The AMMS in Beijing

In October 2011 the drug "Night Eagle", developed to help soldiers cope with sleep deprivation during missions, was unveiled in an exhibition marking the institute's 60th anniversary.[4]

In December 2014, the Chinese government announced that the Academy of Military Medical Sciences had developed an Ebola virus vaccine candidate that had been approved for clinical trials.[1][2]

COVID-19 vaccine

During the COVID-19 pandemic, the AMMS partnered with CanSino Biologics to develop a COVID-19 vaccine. The development team, led by Chen Wei, registered an experimental COVID-19 vaccine for Phase 1 trial on 17 March 2020 to test its safety. The vaccine was tried on 108 healthy volunteers in Wuhan. In April 2020, the vaccine entered Phase 2 to test its effectiveness on 500 volunteers.[5][6] The vaccine was the first one approved outside of clinical trials in an expedite decision, which authorized its use only by the Chinese military.[7]

See also

References
  1. "China's Ebola vaccine enters clinical trials". Retrieved 19 December 2014.
  2. "China approves experimental Ebola vaccine for clinical trials". Reuters. 18 December 2014. Retrieved 19 December 2014.
  3. Patti Waldmeir (October 15, 2014). "China sends thousands of doses of anti-Ebola drug to Africa". Financial Times.
  4. "PLA eyes 'Night Eagle' to make army of night owls". South China Morning Post. 16 October 2011. Retrieved 5 January 2017.
  5. Xie, John (15 April 2020). "China Announces Phase 2 of Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020.
  6. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response". EurekAlert!. 22 May 2020. Retrieved 24 December 2020.
  7. "CanSino's COVID-19 vaccine candidate approved for military use in China". Reuters (in Portuguese). 2020-06-29. Retrieved 2020-07-01.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.